Subscribe

Kneat.com, Inc. (KSIOF)

USD4.60 +0.01 (+0.17%)
IE OTC Healthcare Medical - Healthcare Information Services
Address Castletroy Business Park V94 KW28
Limerick, IE
CEO Edmund Ryan
Website kneat.com
IPO 2014-07-01
ISIN CA4988241010

Explore sections of this company profile

Also trades on Other OTC · KSIOF (USD) Toronto Stock Exchange · KSI.TO (CAD)
Description

Kneat.com, Inc. specializes in providing software solutions for streamlining data and document management within highly regulated sectors. The company operates globally, with a presence in the United States, Ireland, and Canada, among other international markets. Its flagship product is the Kneat Gx platform, a configurable, commercial off-the-shelf (COTS) application purpose-built for managing the entire validation lifecycle and associated testing. This powerful tool serves the biotechnology, pharmaceutical, and medical device manufacturing industries. The platform's capabilities encompass a broad spectrum of validation types, such as process, computer system, cleaning, analytical instrument, method, utility and facility, equipment, and cold chain validation. Additionally, it facilitates commissioning, qualification, and electronic logbook management. Kneat.com, Inc. further complements its software offerings with a comprehensive suite of services. These include implementation support like training and installation, system upgrades, expert consulting, and ongoing maintenance. The company also extends its expertise to process mapping, project management, and other strategic services. Headquartered in Limerick, Ireland, Kneat.com, Inc. leads this global effort.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD4.60 +0.01 (+0.17%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
54.0K
Beta
1.35
Float Shares
74.72M
Free Float %
78.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-2.40% +6.71% +22.41% +22.41% +25.77% +3.39% -22.95% +83.00% +46.61% +1,238.70% +1,237.23%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (1 ratings, all time) Buy
Price Targets & DCF
Current price
4.60
DCF (Unlevered) 0.54 -88.1%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Quality scores
Altman Z-Score
3.32
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Healthcare Information Services: +14.2%
    +29.2% ★ Q1'26: +22.4% (vs Q1'25)
  • ✗
    EPS growth Medical - Healthcare Information Services: +43.1%
    +72.7% ★ Q1'26: -306.5% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    +6.2% Q1'26: +41.5% (vs Q1'25)
  • ✗
    EBIT margin Medical - Healthcare Information Services: +8.8%
    -13.4% Q1'26: -12.9% (vs Q1'25)
  • ✗
    ROIC Medical - Healthcare Information Services: +5.2%
    -16.5% Q1'26: -24.3% (vs Q1'25)
  • ✗
    Share dilution Medical - Healthcare Information Services: -0.1%
    +10.9% Q1'26: -2.0% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    6.32× ★ Q1'26: 4.15× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.32) × ERP
WACC = 93% × Ke + 7% × Kd (9.8%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 0.54 Current price: 4.60
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
5 Rev. Ana.
1 EPS Ana. 		Dec 2027
5 Rev. Ana.
1 EPS Ana. 		Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
1.31M
est: 1.22M (+7.3%)
3.95M
est: 3.86M (+2.4%)
7.42M
est: 6.51M (+13.9%)
15.50M
est: 13.78M (+12.5%)
23.75M
est: 23.09M (+2.9%)
34.22M
est: 33.89M (+1.0%)
48.94M
est: 48.95M (0.0%)
63.21M
est: 63.43M (-0.4%)
79.28M
76.33M – 81.42M
+25.0% YoY
98.24M
93.83M – 99.77M
+23.9% YoY
119.98M
115.00M – 122.46M
+22.1% YoY
EBITDA
-3.64M
est: -198.6K (-1,731.0%)
-2.98M
est: -629.2K (-374.0%)
-2.30M
est: -1.06M (-116.8%)
-5.11M
est: -2.25M (-127.4%)
-3.20M
est: -3.77M (+14.9%)
-5.77M
est: -5.53M (-4.3%)
6.27M
est: 22.09M (-71.6%)
5.54M
est: 28.63M (-80.6%)
35.78M
34.45M – 36.75M
+25.0% YoY
44.34M
42.35M – 45.03M
+23.9% YoY
54.15M
51.90M – 55.27M
+22.1% YoY
EBIT
-4.58M
est: -536.4K (-754.7%)
-6.13M
est: -1.70M (-260.7%)
-5.50M
est: -2.87M (-91.7%)
-9.55M
est: -6.07M (-57.4%)
-8.90M
est: -10.17M (+12.4%)
-13.38M
est: -14.92M (+10.3%)
-3.87M
est: 14.48M (-126.7%)
-8.44M
est: 18.76M (-145.0%)
23.44M
22.57M – 24.08M
+25.0% YoY
29.05M
27.75M – 29.51M
+23.9% YoY
35.48M
34.01M – 36.21M
+22.1% YoY
Net Income
-4.61M
est: -8.32M (+44.6%)
-6.20M
est: -8.79M (+29.5%)
-5.69M
est: -7.15M (+20.4%)
-9.86M
est: -12.07M (+18.3%)
-9.15M
est: -12.39M (+26.1%)
-14.12M
est: -15.90M (+11.2%)
-7.73M
est: -8.86M (+12.8%)
-2.35M
est: -1.21M (-93.8%)
-4.18M
-4.29M – -3.95M
-245.1% YoY
2.59M
2.45M – 2.66M
+162.0% YoY
6.76M
6.40M – 6.94M
+161.0% YoY
SGA
2.94M
est: 664.8K (+342.8%)
3.39M
est: 2.11M (+60.9%)
4.13M
est: 3.56M (+16.2%)
7.35M
est: 7.52M (-2.3%)
13.44M
est: 12.60M (+6.6%)
20.98M
est: 18.50M (+13.4%)
25.44M
est: 26.58M (-4.3%)
34.28M
est: 34.44M (-0.5%)
43.05M
41.45M – 44.21M
+25.0% YoY
53.34M
50.95M – 54.18M
+23.9% YoY
65.15M
62.45M – 66.49M
+22.1% YoY
EPS
-0.09
est: -0.10 (+4.3%)
-0.11
est: -0.10 (-7.1%)
-0.09
est: -0.08 (-3.3%)
-0.13
est: -0.14 (+7.8%)
-0.12
est: -0.14 (+17.1%)
-0.18
est: -0.19 (+3.1%)
-0.09
est: -0.09 (+3.3%)
-0.02
est: -0.01 (-93.6%)
-0.04
-0.05 – -0.04
-245.1% YoY
0.03
0.03 – 0.03
+162.0% YoY
0.07
0.07 – 0.07
+161.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-14 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-13 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-12 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-11 D+ 1/5 1/5 1/5 1/5 2/5 1/5 1/5
2026-05-08 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-04 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-01 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-29 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-28 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-27 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-24 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
64.7K
OE per share TTM
0.00
Owner's Yield
0.02%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
24.6%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-28.4K
Shares Outstanding
95.79M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Jacob Hahn Michelsen Senior Vice President of Sales & Marketing 420.2K male
Edmund Ryan Co-Founder, Chief Executive Officer, President & Executive Director 345.7K male
Kevin Fitzgerald Co-founder & Chief Innovation Officer 250.5K male
Keith Holmes Chief Technology Officer 244.4K male
Brian Ahearne Co-Founder, Director of Information Security & IT Operations and Company Secretary 239.1K male
Dave O'Reilly Chief Financial Officer 205.4K male
Fiona McCarthy Chief People & Culture Officer — female
Donal O'Sullivan Chief Product Officer — male
Katie Keita IR Lead — female
Colum McNamara Senior Vice President of Global Operations — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Healthcare Information Services